Infant healthcare utilization
perinatal hepatitis C
HEPATITIS C
Data are abstracted from the child’s EMR at the end of the 18-month follow-up period, including receipt of on-time immunizations and screenings (i.e., lead, hemoglobin, and developmental assessments); infant hepatitis C screening at 18 months among those with perinatal hepatitis C exposure; the number of acute primary care visits (“sick visits”); emergency department utilization and hospitalizations; subspecialist referrals and visits (e.g., Neurology, Ophthalmology, Developmental Medicine); and early intervention referral and enrollment. The proportion of participants who receive these services within the 18-month study period will be compared between the 2 study arms. The mean number of hospitalizations and sick, emergency, and specialist visits will also be compared between the 2 groups.